These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25515688)

  • 1. Hemoglobinopathy screening by osmotic fragility test based on flow cytometer or naked eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2016 May; 90(3):279-84. PubMed ID: 25515688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobinopathy Screening by Osmotic Fragility Test Based on Flow Cytometer or Naked Eye.
    Mohapatra R; Warang P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2014 Nov; ():. PubMed ID: 25421017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NESTROFF as a screening test for detection of Beta-thalassemia trait.
    Bobhate SK; Gaikwad ST; Bhaledrao T
    Indian J Pathol Microbiol; 2002 Jul; 45(3):265-7. PubMed ID: 12785163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of naked eye single tube red cell osmotic fragility test in detecting beta-thalassemia trait.
    Raghavan K; Lokeshwar MR; Birewar N; Nigam V; Manglani MV; Raju NB
    Indian Pediatr; 1991 May; 28(5):469-72. PubMed ID: 1752672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
    Mamtani M; Jawahirani A; Das K; Rughwani V; Kulkarni H
    Hematology; 2006 Aug; 11(4):277-86. PubMed ID: 17178668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric osmotic fragility test: Increased assay sensitivity for clinical application in pediatric hematology.
    Ciepiela O; Adamowicz-Salach A; Zgodzińska A; Łazowska M; Kotuła I
    Cytometry B Clin Cytom; 2018 Jan; 94(1):189-195. PubMed ID: 28103644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NESTROFT as a screening test for the detection of thalassaemia & common haemoglobinopathies--an evaluation against a high performance liquid chromatographic method.
    Thomas S; Srivastava A; Jeyaseelan L; Dennison D; Chandy M
    Indian J Med Res; 1996 Aug; 104():194-7. PubMed ID: 8840659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of single-tube osmotic fragility as a screening test for thalassemia.
    Chow J; Phelan L; Bain BJ
    Am J Hematol; 2005 Jul; 79(3):198-201. PubMed ID: 15981230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'NESTROFT'--an effective screening test for beta thalassemia trait.
    Manglani M; Lokeshwar MR; Vani VG; Bhatia N; Mhaskar V
    Indian Pediatr; 1997 Aug; 34(8):702-7. PubMed ID: 9492398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of Nestroft in screening and diagnosis of beta-thalassemia trait.
    Gomber S; Sanjeev ; Madan N
    J Trop Pediatr; 1997 Dec; 43(6):363-6. PubMed ID: 9476460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of β-Thalassemia and hemoglobin E in two migrant populations of Manipur, North East India.
    Achoubi N; Asghar M; Saraswathy KN; Murry B
    Genet Test Mol Biomarkers; 2012 Oct; 16(10):1195-200. PubMed ID: 23057593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of red cell osmotic fragility test with varying degrees of saline concentration in detecting beta-thalassaemia trait.
    Singh SP; Gupta SC
    Singapore Med J; 2008 Oct; 49(10):823-6. PubMed ID: 18946618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NESTROFT - A Valuable, Cost Effective Screening Test for Beta Thalassemia Trait in North Indian Punjabi Population.
    Piplani S; Manan R; Lalit M; Manjari M; Bhasin T; Bawa J
    J Clin Diagn Res; 2013 Dec; 7(12):2784-687. PubMed ID: 24551637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for the carriers of thalassemias and abnormal hemoglobins at the community level.
    Winichagoon P; Thitivichianlert A; Lebnak T; Piankijagum A; Fucharoen S
    Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():145-50. PubMed ID: 12755285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NESTROFT-A Cost-Effective Mass Screening Tool for the Detection of β-Thalassemia Carrier Status in Anemic Pregnant Women: A Step Toward Reducing the National Disease Burden.
    Gosavi M; Chavan R; Bellad MB
    J Lab Physicians; 2021 Dec; 13(4):368-373. PubMed ID: 34975258
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometric osmotic fragility--an effective screening approach for red cell membranopathies.
    Warang P; Gupta M; Kedar P; Ghosh K; Colah R
    Cytometry B Clin Cytom; 2011 May; 80(3):186-90. PubMed ID: 21298775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
    Sangkitporn S; Sangkitporn S; Sangnoi A; Supangwiput O; Tanphaichitr VS
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1538-42. PubMed ID: 16610659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
    Rodriguez-Capote K; Higgins TN
    Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Flow-Cytometric Osmotic Fragility Test for Hereditary Spherocytosis in Chinese Patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Deng XL; Chen WQ; Lin FQ
    Acta Haematol; 2016; 135(2):88-93. PubMed ID: 26505491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.